Drug Type iNKT cell therapy, CAR-NKT |
Synonyms GKL 006, GKL-006, GKL006 |
Target |
Action inhibitors |
Mechanism GPC3 inhibitors(Glypican-3 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePhase 2 |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Unresectable Hepatocellular Carcinoma | Phase 2 | China | 10 Sep 2025 | |
| Pancreatic Cancer | Phase 2 | China | 04 Aug 2025 | |
| Psoriasis | IND Approval | China | 12 Feb 2026 |





